Skip to main content
SpringerLink
Log in

Medical Complications in Patients after Cardiac Transplantation

  • Chapter
Cardiac Transplantation

  • 51 Accesses

Abstract

Although cardiologists and cardiac surgeons commonly serve as the primary care physicians for cardiac transplant recipients, the complications that develop may transcend their specific area of expertise and training.1 Despite the functional differences between the denervated allograft and the normal heart, severe cardiac dysfunction is distinctly unusual.2 The medical complications that follow cardiac transplantation involve multiple organ systems and require the input of specialists in such broad areas as infectious diseases, nephrology, gastroenterology, neurology, endocrinology, gynecology, pulmonology, and oncology. Therefore, the physician who is primarily responsible for the patient’s care must assume the role of a generalist and recruit the support of the appropriate specialists when necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. O’Connell JB, Renlund DG, Bristow MR. Cardiac transplantation: emerging role of the internist/cardiologist. J Intern Med. 1989;225:147–156.

    Article  PubMed  Google Scholar 

  2. Hosenpud JD, Morton MJ. Hemodynamic assessment and physiology of the transplanted heart. In: Hosenpud JD, Cobanoglu A, Norman D, Starr A, eds. Cardiac Transplantation: A Manual for Health Care Professionals and Trainees New York, NY: Springer-Verlag. In press.

    Google Scholar 

  3. O’Connell JB, Renlund DG, Lee HR, et al. Newer techniques of immunosuppression in cardiac transplantation. Cardiac Surgery: State of the Art Reviews 1988;2:607–615.

    Google Scholar 

  4. Fragomeni LS, Kaye, MP. The Registry of the International Society for Heart Transplantation: fifth official report—1988. J Heart Transplant. 1988;7:249–253.

    PubMed  CAS  Google Scholar 

  5. Mason JW, Stinson EB, Hunt SA, et al. Infections after cardiac transplantation: relation to rejection therapy. Ann Intern Med. 1976;85:69–72.

    PubMed  CAS  Google Scholar 

  6. Hofflin JA, Potasman I, Baldwin JC, et al. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med. 1987;106:209–216.

    PubMed  CAS  Google Scholar 

  7. Dresdale AR, Drusin RE, Lamb J, et al. Reduced infection in cardiac transplant recipients. Circulation. 1985;72(suppl II):237–240.

    Google Scholar 

  8. Report of the Working Group of Transplant Cardiologists, Chicago, Ill 1989. Unpublished.

    Google Scholar 

  9. Trento A, Dummer GS, Hardesty RL. Mediastinitis following heart transplantation: incidence, treatment, and results. Heart Transplant. 1984;3:336–340.

    Google Scholar 

  10. Miller R, Ruder J, Karwande SV, et al. Treatment of mediastinitis after heart transplantation. J Heart Transplant. 1986;5:477–479.

    PubMed  CAS  Google Scholar 

  11. Gottesdiener KM. Transplanted infections: donor-to-host transmission with the allograft. Ann Intern Med. 1989;110:1001–1016.

    PubMed  CAS  Google Scholar 

  12. Guttendorf J, Bohachick P, Dummer JS, et al. The impact of protective isolation on the incidence of early infection in adult heart transplant patients. Circulation. 1988;78(suppl II):II–3. Abstract.

    Google Scholar 

  13. Dummer JS, White LT, Ho M, et al. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis. 1985;152:1182–1191.

    Article  PubMed  CAS  Google Scholar 

  14. Collier AC, Chandler SH, Handsfield HH, et al. Identification of multiple strains of cytomegalovirus in homosexual men. J Infect Dis. 1989;159:123–126.

    Article  PubMed  CAS  Google Scholar 

  15. Smith CB. Cytomegalovirus pneumonia state of the art. Chest. 1989;95(suppl):182S–187S.

    Article  Google Scholar 

  16. Bloom JN, Palestine AG. The diagnosis of cytomegalovirus retinitis. Ann Intern Med. 1988;109:963–969.

    PubMed  CAS  Google Scholar 

  17. Gonwa TA, Capehart JE, Pilcher JW, et al. Cytomegalovirus myocarditis as a cause of cardiac dysfunction in a heart transplant recipient. Transplantation. 1989;47:197–199.

    PubMed  CAS  Google Scholar 

  18. Watson FS, O’Connell JB, Amber IJ, et al. Treatment of cytomegalovirus pneumonia in heart transplant recipients with 9(1,3-dihydroxy-2-proproxy-methyl)-guanine (DHPG). J Heart Transplant. 1988;7:102–105.

    PubMed  CAS  Google Scholar 

  19. Keay S, Petersen E, Icenogle T, et al. Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients. Rev Infect Dis. 1988;10(suppl 3):S563-S572.

    Article  PubMed  Google Scholar 

  20. Reed EC, Bowden RA, Dandliker PS, et al. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med. 1988;109:783–788.

    PubMed  CAS  Google Scholar 

  21. Emanuel D, Cunningham I, Jules-Elysee K, et al. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med. 1988;109:777–782.

    PubMed  CAS  Google Scholar 

  22. Snydman DR, Werner BG, Heinze-Lacey B, et al. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med. 1987;317:1049–1054.

    Article  PubMed  CAS  Google Scholar 

  23. Balfour HH, Chace BA, Stapleton JT, et al. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med. 1989;320:1381–1387.

    Article  PubMed  Google Scholar 

  24. Luft BJ, Naot Y, Araujo F, et al. Primary and reactivated toxoplasma infection in patients with cardiac transplant. Ann Intern Med. 1983;99:27–31.

    PubMed  CAS  Google Scholar 

  25. Luft BJ, Billingham M, Remington JS. Endomyocardial biopsy in the diagnosis of toxoplasmic myocarditis. Transplant Proc. 1986;18:1871–1873.

    PubMed  CAS  Google Scholar 

  26. Leport C, Raffi F, Matheron S, et al. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Am J Med. 1988;84:94–100.

    Article  PubMed  CAS  Google Scholar 

  27. Dannemann BR, Israelski DM, Remington JS. Treatment of toxoplasmic encephalitis with intravenous clindamycin. Arch Intern Med. 1988;148:2477–2482.

    Article  PubMed  CAS  Google Scholar 

  28. Cohen ND, Munoz A, Reitz BA, et al. Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med. 1989;320:1172–1176.

    Article  PubMed  CAS  Google Scholar 

  29. Rubin RH, Tolkoff-Rubin NE. The problem of human immunodeficiency virus (HIV) infection and transplantation. Transplant Int. 1988;1:36–42.

    Article  CAS  Google Scholar 

  30. Peters SG, Prakash UBS. Pneumocystis carinii pneumonia. Am J Med. 1987;82:73–78.

    Article  PubMed  CAS  Google Scholar 

  31. Franson RT, Kauffman HM Jr, Adams MB, et al. Cyclosporine therapy and refractory Pneumocystis carinii pneumonia. Arch Surg. 1987;122:1034–1035.

    PubMed  CAS  Google Scholar 

  32. Higgins RM, Bloom SL, Hopkin JM, et al. The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation. Transplantation. 1989;47:558–560.

    Article  PubMed  CAS  Google Scholar 

  33. Golden JA, Chernoff D, Hollander H, et al. Prevention of Pneumocystis carinii pneumonia by inhaled pentamidine. Lancet. 1989;1:654–657.

    Article  PubMed  CAS  Google Scholar 

  34. Favor A, Frazier OH, Cooley DA, et al. Legionella infections in cyclosporine-immunosuppressed cardiac transplants. Tex Heart Inst J. 1985;12:153–156.

    PubMed  CAS  Google Scholar 

  35. Marget W, Seeliger HPR. Listeria monocytogenes infections-therapeutic possibilities and problems. Infection. 1988;16(suppl 2):S175-S177.

    Article  PubMed  Google Scholar 

  36. Seale L, Jones CJ, Kathpalia S, et al. Prevention of herpesvirus infections in renal allograft recipients by lowdose oral acyclovir. JAMA. 1985;254:3435–3438.

    Article  PubMed  CAS  Google Scholar 

  37. Gombert ME, duBouchet L, Aulicino TM, et al. A comparative trial of clotrimazole troches and oral nystatin suspension in recipients of renal transplants. JAMA. 1987;258:2553–2555.

    Article  PubMed  CAS  Google Scholar 

  38. Wilson JP, Turner HR, Kirchner KA, et al. Nocardia infections in renal transplant recipients. Medicine. 1989;68:38–53.

    Article  PubMed  CAS  Google Scholar 

  39. Wiebe VJ, DeGregorio MW. Liposome-encapsulated amphotericin B: a promising new treatment for disseminated fungal infections. Rev Infect Dis. 1988;10:1097–1101.

    Article  PubMed  CAS  Google Scholar 

  40. Radovancevic B, Frazier OH, Gentry LO, et al. Successful treatment of invasive aspergillosis in a heart transplant patient. Tex Heart Inst J. 1985;12:233–237.

    PubMed  CAS  Google Scholar 

  41. Renlund DG, O’Connell JB, Gilbert EM, et al. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Transplantation. 1989;47:599–605.

    Article  PubMed  CAS  Google Scholar 

  42. Renlund DG, O’Connell JB, Gilbert EM, et al. Feasibility of discontinuation of corticosteroid maintenance therapy in heart transplantation. J Heart Transplant. 1987;6:71–78.

    PubMed  CAS  Google Scholar 

  43. Oh CH, Stratta RB, Fox BC, et al. Increased infections associated with the use of OKT3 for treatment of steroid- resistant rejection in renal transplantation. Transplantation. 1988;45:68–73.

    Article  PubMed  CAS  Google Scholar 

  44. Munda R, Hutchins M, First MR, et al. Infection in OKT3-treated patients receiving additional antirejection therapy. Transplant Proc. 1989;21:1763–1765.

    PubMed  CAS  Google Scholar 

  45. Singh N, Dummer JS, Kusne S, et al. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis. 1988;158:124–131.

    Article  PubMed  CAS  Google Scholar 

  46. Hosenpud JD, Norman DJ, Pantley GA, et al. Low morbidity and mortality from infection following cardiac transplantation using maintenance triple therapy and low-dose corticosteroids for acute rejection. Clin Transplant. 1988;2:201–206.

    Google Scholar 

  47. Renlund DG, O’Connell JB, Bristow MR. Early rejection prophylaxis in heart transplantation: Is cytolytic therapy necessary? J Heart Transplant. 1989;8:191–193.

    PubMed  CAS  Google Scholar 

  48. Wenting GJ, Van den Meiracker AH, Ritsema van Eck HJ, et al. Lack of circadian variation of blood pressure after heart transplantation. J Hypertension. 1986;4(suppl 6):S78-S80.

    Google Scholar 

  49. Reeves RA, Shapiro AP, Thompson ME, et al. Loss of nocturnal decline in blood pressure after cardiac transplantation. Circulation. 1986;73:401–408.

    Article  PubMed  CAS  Google Scholar 

  50. Thompson ME, Shapiro AP, Johnsen AM, et al. The contrasting effects of cyclosporin-A and azathioprine on arterial blood pressure and renal function following cardiac transplantation. Int J Cardiol. 1986;11:219–229.

    Article  PubMed  CAS  Google Scholar 

  51. Curtis JJ, Luke RG, Jones P, et al. Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent. Am J Med. 1988;85:134–138.

    Article  PubMed  CAS  Google Scholar 

  52. Bantle JP, Boudreau RJ, Ferris TF. Suppression of plasma renin activity by cyclosporine. Am J Med. 1987;83:59–64.

    Article  PubMed  CAS  Google Scholar 

  53. Bennett WM, Porter GA. Cyclosporine-associated hypertension. Am J Med. 1988;85:131–133.

    Article  PubMed  CAS  Google Scholar 

  54. Jessup M, Cavarocchi N, Narins B, et al. Antihypertensive therapy in patients after cardiac transplantation: a step-care approach. Transplant Proc. 1988;20(suppl l):801–802.

    Google Scholar 

  55. Ratkovec RM, Renlund DG, Bristow MR, et al. Diltiazem treatment of cyclosporine-induced hypertension after cardiac transplantation. Cardiovasc Drugs Ther. 1989,3:622. Abstract.

    Google Scholar 

  56. Shaunak S, Munro JM, Weinbren K, et al. Cyclophosphamide-induced liver necrosis: a possible interaction with azathioprine. Q J Med 1988;67:309–317.

    PubMed  CAS  Google Scholar 

  57. Aziz S, Bergdahl L, Baldwin JC, et al. Pancreatitis after cardiac and cardiopulmonary transplantation. Surgery. 1985;97:653–661.

    PubMed  CAS  Google Scholar 

  58. Merrell SW, Ames SA, Nelson EW, et al. Major abdominal complications following cardiac transplantation. Arch Surg. 1989;124:889–894.

    PubMed  CAS  Google Scholar 

  59. Meyers BD, Ross J, Newton L, et al. Cyclosporine-associated chronic nephropathy. N Engl J Med. 1984;311:699–705.

    Article  Google Scholar 

  60. Greenberg A, Egel JW, Thompson ME, et al. Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients. Am J Kidney Dis. 1987;9:12–22.

    PubMed  CAS  Google Scholar 

  61. Roth D, Milgrom M, Esquenazi V, et al. Posttransplant hyperglycemia. Transplantation. 1989;47:278–281.

    Article  PubMed  CAS  Google Scholar 

  62. Ibels LS, Alfrey AC, Huffer WE, Weil R. Aseptic necrosis of bone after renal transplantation: experience in 194 transplant recipients and review of the literature. Medicine. 1978;57:25–45.

    Article  PubMed  CAS  Google Scholar 

  63. Hyams JS, Carey DE. Corticosteroids and growth. J Pediatr. 1988;113:249–254.

    Article  PubMed  CAS  Google Scholar 

  64. Kossoy LR, Herbert CM, Wentz AC. Management of heart transplant recipients: guidelines for the obstetrician-gynecologist. Am J Obstet Gynecol. 1988;159:490–499.

    PubMed  CAS  Google Scholar 

  65. Yeast JD. Immunosuppressives in pregnant transplant patients—what risks? Contemp OBIGYN. 1987;30:117–124.

    Google Scholar 

  66. Bolton AE, Pockley AG, Clough KU, et al. Identification of placental protein 14 as an immunosuppressive factor in human reproduction. Lancet. 1987;1:593–595.

    Article  PubMed  CAS  Google Scholar 

  67. Lowenstein BR, Vain NW, Perrone SV, et al. Successful pregnancy and vaginal delivery after heart transplantation. Am J Obstet Gynecol. 1988;158:589–590.

    PubMed  CAS  Google Scholar 

  68. Zimmerman J, Fainaru M, Eisenberg S. The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: a prospective study. Metabolism. 1984;33:521–526.

    Article  PubMed  CAS  Google Scholar 

  69. Stamler JS, Vaughan DE, Rudd MA, et al. Frequency of hypercholesterolemia after cardiac transplantation. Am J Cardiol. 1988;62:1268–1272.

    Article  PubMed  CAS  Google Scholar 

  70. Becker DM, Chamberlain B, Swank R, et al. Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients. Am J Med. 1988;85:632–638.

    Article  PubMed  CAS  Google Scholar 

  71. Renlund DG, Bristow MR, Crandall BG, et al. Hypercholesterolemia after heart transplantation: amelioration by corticosteroid-free maintenance immunosuppression. J Heart Transplant. 1989;8:214–220.

    PubMed  CAS  Google Scholar 

  72. Corpier CL, Jones PH, Suki WN, et al. Rhabdomyolysis and renal injury with lovastatin use. JAMA. 1988;260:239–241.

    Article  PubMed  CAS  Google Scholar 

  73. Miller LW, Noedel N, Pennington DG. Treatment of hypercholesterolemia in cardiac transplant recipients with lovastatin. Presented to the 8th Annual Meeting of the American Society of Transplant Physicians Chicago, Ill; 1989. Abstract.

    Google Scholar 

  74. Grigg MM, Costanzo-Nordin MR, Celesia GG, et al. The etiology of seizures after cardiac transplantation. Transplant Proc. 1988;20(suppl 3):937–944.

    PubMed  CAS  Google Scholar 

  75. Penn I. Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery. 1978;83:492–502.

    PubMed  CAS  Google Scholar 

  76. Anderson JL, Fowles RE, Bieber CP, et al. Idiopathic cardiomyopathy, age, and suppressor-cell dysfunction as risk determinants of lymphoma after cardiac transplantation. Lancet. 1978;2:1174–1177.

    Article  PubMed  CAS  Google Scholar 

  77. Pennl. Cancers following cyclosporine therapy. Transplantation. 1987;43:32–35.

    Article  Google Scholar 

  78. Cleary ML, Sklar J. Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet. 1984;2:491–493.

    Google Scholar 

  79. Hanto DW, Gajl-Peczalska KJ, Balfour HH, et al. Acyclovir therapy of Ep-stein-Barr virus-induced posttransplant lymphoproliferative diseases. Transplant Proc. 1985;17:89–92.

    Google Scholar 

  80. Billingham ME. Cardiac transplant atherosclerosis. Transplant Proc. 1987;19(suppl 5):19–25.

    PubMed  CAS  Google Scholar 

  81. Palmer DC, Tsai CC, Roodman ST, et al. Heart graft arteriosclerosis—an ominous finding on endomyocardial biopsy. Transplantation. 1985;39:385–388.

    Article  PubMed  CAS  Google Scholar 

  82. Valantine HA, Mullin AV, Hunt SA, et al. Detection of accelerated graft atherosclerosis: importance of hemodynamic response to exercise. Circulation. 1988;78(suppl II):II–252. Abstract.

    Google Scholar 

  83. Uretsky BF, Murali S, Reddy PS, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation. 1987;76:827–834.

    Article  PubMed  CAS  Google Scholar 

  84. Gao SZ, Schroeder J, Alderman E, et al. Incidence of accelerated coronary artery disease in heart transplant survivors: comparison of cyclosporin and azathioprine regimen. Circulation. 1988;78(suppl II):II–280. Abstract.

    Google Scholar 

  85. Ratkovec RM, Wray RB, Renlund DG, et al. Corticosteroid-free maintenance immunosuppression in allograft coronary artery disease following cardiac transplantation. J Thorac Cardiovasc Surg. 1990;100:6–12.

    PubMed  CAS  Google Scholar 

  86. Hess ML, Hastillo A, Mohanakumar T, et al. Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B- cell antibodies and hyperlipidemia. Circulation. 1983;68(suppl II):II–94-II-101.

    Google Scholar 

  87. Petrossian GA, Hernadi S, Nichols AB, et al. Increased mortality and coronary artery disease in cardiac transplant recipients with lymphocytotoxic anti-HLA antibodies. Circulation. 1988;78(suppl II):II–86. Abstract.

    Google Scholar 

  88. Grattan MT, Moreno-Cabral CE, Starnes VA, et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 1989;261:3561–3566.

    Article  PubMed  CAS  Google Scholar 

  89. Griepp RB, Stinson EB, Bieber CP, et al. Control of graft arteriosclerosis in human heart transplant recipients. Surgery. 1977;81:262–269.

    PubMed  CAS  Google Scholar 

  90. Vetrovec GW, Cowley MJ, Newton CM, et al. Applications of percutaneous transluminal coronary angioplasty in cardiac transplantation. Circulation. 1988;78(suppl III):III–83-III-86.

    Google Scholar 

  91. Gao SZ, Schroeder JS, Hunt S, et al. Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. Am J Cardiol. 1988;62:876–881.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. John B. O’Connell
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Oregon Health Sciences University, Portland, Oregon, 97201, USA

    Jeffrey D. Hosenpud M.D. (Associate Professor of Medicine/Cardiology, Head, Cardiac Transplant Medicine), Adnan Cobanoglu M.D. (Professor of Surgery and Chief, Cardiopulmonary Surgery, Director, Heart Transolantation Program), Douglas J. Norman M.D. (Professor of Medical, Director, Transplantation and Immunogenetics Laboratory, Director, Medical Transplantation Program) & Albert Starr M.D. (Professor of Surgery) (Associate Professor of Medicine/Cardiology, Head, Cardiac Transplant Medicine),  (Professor of Surgery and Chief, Cardiopulmonary Surgery, Director, Heart Transolantation Program),  (Professor of Medical, Director, Transplantation and Immunogenetics Laboratory, Director, Medical Transplantation Program) &  (Professor of Surgery)

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

O’Connell, J.B. (1991). Medical Complications in Patients after Cardiac Transplantation. In: Hosenpud, J.D., Cobanoglu, A., Norman, D.J., Starr, A. (eds) Cardiac Transplantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3008-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3008-3_11

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7757-6

  • Online ISBN: 978-1-4612-3008-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation